세계의 바이오메디컬 센서 시장 전망(-2030년) : 제품 유형, 센서 유형, 연결성, 용도, 최종 사용자, 지역별 분석

According to Stratistics MRC, the Global Biomedical Sensor Market is accounted for $10.7 billion in 2024 and is expected to reach $17.8 billion by 2030, growing at a CAGR of 8.8% during the forecast period. A biomedical sensor is a device used to monitor a person's health by detecting and measuring biological signals or parameters, such as temperature, blood pressure, heart rate, or glucose levels. These sensors help with disease diagnosis, treatment monitoring, and patient care by converting physiological data into electrical signals for analysis. Wearable technology, diagnostic tools, and medical implants all use biomedical sensors to provide real-time health monitoring and enable tailored medical interventions for better results.

According to the World Health Organization (WHO), chronic diseases such as cardiovascular diseases and diabetes affected approximately 537 million adults globally in 2021.

Market Dynamics:

Driver:

Increased demand for patient monitoring

The growing prevalence of chronic diseases and an aging population have led to increased demand for patient monitoring systems. Biomedical sensors enable continuous, real-time monitoring of vital signs and other health parameters, allowing for early detection of health issues and timely interventions. This trend is driving the adoption of biomedical sensors in healthcare settings and home care environments, fueling market growth.

Restraint:

Security concerns

The integration of biomedical sensors with connected devices and networks raises concerns about data security and patient privacy. Unauthorized access to sensitive health information could lead to breaches of confidentiality and potential misuse of data. These security risks may hinder the widespread adoption of biomedical sensors, particularly in healthcare institutions and among privacy-conscious individuals, thus restraining market growth.

Opportunity:

Growing healthcare expenditure

Increasing healthcare expenditure worldwide presents a significant opportunity for the biomedical sensors market. As governments and private sectors invest more in healthcare infrastructure and advanced medical technologies, the demand for sophisticated monitoring and diagnostic tools incorporating biomedical sensors is expected to rise. This trend is particularly pronounced in emerging economies, where healthcare systems are rapidly modernizing.

Threat:

Changes in healthcare regulations

The biomedical sensors market faces potential threats from evolving healthcare regulations and standards. Stringent regulatory requirements for medical devices, including sensors, can lead to longer product development cycles and increased costs. Additionally, changes in reimbursement policies may affect the adoption of sensor-based technologies in healthcare settings. These regulatory uncertainties could pose challenges to market players and impact growth trajectories.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the biomedical sensors market. Initially, supply chain disruptions and manufacturing slowdowns caused temporary setbacks. However, the pandemic also accelerated the adoption of remote patient monitoring solutions and telehealth services, driving demand for biomedical sensors. The need for continuous monitoring of COVID-19 patients' vital signs in hospitals and home care settings further boosted market growth. Long-term effects include increased awareness of personal health monitoring and a shift towards preventive healthcare, benefiting the biomedical sensors market.

The non-invasive sensors segment is expected to be the largest during the forecast period

The non-invasive sensors segment is predicted to secure the largest market share throughout the forecast period due to their advantages in patient comfort and ease of use. These sensors can monitor various physiological parameters without breaking the skin or entering body cavities, making them ideal for continuous monitoring and home healthcare applications. Non-invasive sensors also offer reduced risk of infection and complications compared to invasive alternatives. The growing preference for minimally invasive medical procedures and the increasing adoption of wearable health devices contribute to this segment's dominance.

The bioanalytic sensors segment is expected to have the highest CAGR during the forecast period

The bioanalytic sensors segment is projected to witness substantial growth during the projection period. These sensors are designed to detect and measure specific biological or chemical substances in the body, offering high sensitivity and selectivity. The increasing focus on personalized medicine, point-of-care diagnostics, and continuous monitoring of biomarkers for various diseases drives the demand for bioanalytic sensors. Furthermore, advancements in nanotechnology and materials science are enhancing the capabilities of these sensors, enabling rapid, accurate, and cost-effective analysis of complex biological samples.

Region with largest share:

North America is expected to hold the largest share in the biomedical sensors market during the forecast period. This dominance is attributed to several factors, including advanced healthcare infrastructure, high healthcare expenditure, and early adoption of innovative medical technologies. The region's strong presence of leading medical device manufacturers and research institutions contributes to continuous innovation in sensor technologies. Additionally, the high prevalence of chronic diseases and an aging population drive the demand for advanced patient monitoring solutions incorporating biomedical sensors.

Region with highest CAGR:

The Asia Pacific region is projected to achieve the highest CAGR in the biomedical sensors market. Rapid economic growth, increasing healthcare expenditure, and improving healthcare infrastructure in countries like China and India are driving market expansion. The region's large and growing population, coupled with rising awareness of preventive healthcare, creates a substantial market for biomedical sensors. Additionally, government initiatives to modernize healthcare systems and the increasing adoption of digital health technologies further contribute to the region's high growth rate in the market.

Key players in the market

Some of the key players in Biomedical Sensor Market include GE Healthcare, Analog Devices, Inc., STMicroelectronics N.V., Medtronic PLC, NXP Semiconductor N.V., Honeywell International Inc., Texas Instruments, Nonin Medical Inc., First Sensor AG, Smiths Medical, Measurement Specialties, Inc., LumaSense Technologies, Zephyr Technology Corp., Innovative Sensor Technology USA, and Amphenol Corporation.

Key Developments:

In October 2024, Medtronic has introduced the Nellcor(TM) OxySoft(TM) SpO2 sensor, which uses silicone adhesive to protect fragile skin and improve repositionability. This sensor is designed for critical care patients and provides continuous oxygen saturation monitoring.

In April 2024, Nonin Medical has partnered with Medixine to integrate pulse oximetry devices into a digital remote patient monitoring platform. This collaboration aims to streamline overnight oxygen therapy pre-screening using Nonin's wearable devices.

In January 2024, Amphenol has expanded its sensor portfolio through acquisitions of companies like LID (pressure sensors) and PCTEL (wireless technology). These acquisitions will enhance Amphenol's offerings in medical sensor technologies.

Product Types Covered:

• Invasive Sensors
• Non-Invasive Sensors

Sensor Types Covered:

• Physical Sensors
• Chemical Sensors
• Biological Sensors
• Bioanalytic Sensors

Connectivity's Covered:

• Wired
• Wireless

Applications Covered:

• Vital Signs Monitoring
• Disease Diagnostics
• Surgical Monitoring
• Medical Imaging
• Therapeutic Monitoring
• Remote Patient Monitoring
• Drug Development and Discovery
• Other Applications

End Users Covered:

• Hospitals and Clinics
• Home Healthcare
• Diagnostic Centers
• Research and Academic Institutions
• Ambulatory Care Centers
• Sports and Fitness Institutes

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Biomedical Sensor Market, By Product Type

• 5.1 Introduction
• 5.2 Invasive Sensors
• 5.3 Non-Invasive Sensors

6 Global Biomedical Sensor Market, By Sensor Type

• 6.1 Introduction
• 6.2 Physical Sensors
  • 6.2.1 Mechanical
  • 6.2.2 Hydraulic
  • 6.2.3 Geometric
  • 6.2.4 Electric
  • 6.2.5 Thermal
  • 6.2.6 Optical
• 6.3 Chemical Sensors
  • 6.3.1 Gas
  • 6.3.2 Photometric
  • 6.3.3 Electrochemical
  • 6.3.4 Other Chemical Sensors
• 6.4 Biological Sensors
  • 6.4.1 Body Surface Biopotential Electrode
  • 6.4.2 Intracavitary and Intratissue Electrode
  • 6.4.3 Metal Plate
  • 6.4.4 Microelectrode
• 6.5 Bioanalytic Sensors
  • 6.5.1 Enzymes
  • 6.5.2 Protein
  • 6.5.3 Antigen
  • 6.5.4 Antibody
  • 6.5.5 Ligand
  • 6.5.6 Cell
  • 6.5.7 DNA

7 Global Biomedical Sensor Market, By Connectivity

• 7.1 Introduction
• 7.2 Wired
• 7.3 Wireless

8 Global Biomedical Sensor Market, By Application

• 8.1 Introduction
• 8.2 Vital Signs Monitoring
• 8.3 Disease Diagnostics
• 8.4 Surgical Monitoring
• 8.5 Medical Imaging
• 8.6 Therapeutic Monitoring
• 8.7 Remote Patient Monitoring
• 8.8 Drug Development and Discovery
• 8.9 Other Applications

9 Global Biomedical Sensor Market, By End User

• 9.1 Introduction
• 9.2 Hospitals and Clinics
• 9.3 Home Healthcare
• 9.4 Diagnostic Centers
• 9.5 Research and Academic Institutions
• 9.6 Ambulatory Care Centers
• 9.7 Sports and Fitness Institutes

10 Global Biomedical Sensor Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 GE Healthcare
• 12.2 Analog Devices, Inc.
• 12.3 STMicroelectronics N.V.
• 12.4 Medtronic PLC
• 12.5 NXP Semiconductor N.V.
• 12.6 Honeywell International Inc.
• 12.7 Texas Instruments
• 12.8 Nonin Medical Inc.
• 12.9 First Sensor AG
• 12.10 Smiths Medical
• 12.11 Measurement Specialties, Inc.
• 12.12 LumaSense Technologies
• 12.13 Zephyr Technology Corp.
• 12.14 Innovative Sensor Technology USA
• 12.15 Amphenol Corporation